Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check6 days agoChange DetectedA related topics section has been added featuring Type 2 diabetes and MedlinePlus Genetics. This provides additional background links related to the study without altering its core content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedA new footer revision tag 'Revision: v3.6.3' was added; several navigation/related items were removed, including 'Type 2 diabetes', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.2'.SummaryDifference0.1%

- Check28 days agoChange DetectedType 2 diabetes was added to the related topics and MedlinePlus Genetics was added as a related topic; the revision tag updated from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page’s condition label and related topics section have been shortened by removing 'Type 2 diabetes', the related topics header, and 'MedlinePlus Genetics', altering what is surfaced to users about the condition and related resources.SummaryDifference0.1%

- Check42 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed for this study. The page also adds new help and navigation content ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and related topic links, while the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page now displays the latest site revision, 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. It also removes references to 'Type 2 diabetes' and 'related topics: MedlinePlus Genetics'.SummaryDifference0.1%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.